Immunovant Inc’s recently made public that its Chief Financial Officer Barnett Eva Renee unloaded Company’s shares for reported $44566.0 on Apr 16 ’25. In the deal valued at $14.89 per share,2,993 shares were sold. As a result of this transaction, Barnett Eva Renee now holds 396,774 shares worth roughly $6.01 million.
Then, Salzmann Peter sold 8,321 shares, generating $123,900 in total proceeds. Upon selling the shares at $14.89, the Chief Executive Officer now owns 1,178,191 shares.
Before that, Salzmann Peter sold 28,094 shares. Immunovant Inc shares valued at $364,941 were divested by the Chief Executive Officer at a price of $12.99 per share. As a result of the transaction, Salzmann Peter now holds 1,186,512 shares, worth roughly $17.98 million.
Jefferies initiated its Immunovant Inc [IMVT] rating to a Hold in a research note published on March 03, 2025; the price target was $20. A number of analysts have revised their coverage, including Wolfe Research’s analysts, who decreased its forecast for the stock in early January from “an Outperform” to “a Peer perform”. Oppenheimer maintained its rating on October 09, 2024. It rated IMVT as “an Outperform”.
Price Performance Review of IMVT
On Thursday, Immunovant Inc [NASDAQ:IMVT] saw its stock jump 2.09% to $15.15. Over the last five days, the stock has gained 2.43%. Immunovant Inc shares have fallen nearly -38.84% since the year began. Nevertheless, the stocks have fallen -50.16% over the past one year. While a 52-week high of $34.47 was reached on 01/02/25, a 52-week low of $12.72 was recorded on 04/09/25. SMA at 50 days reached $18.37, while 200 days put it at $25.63.
Levels Of Support And Resistance For IMVT Stock
The 24-hour chart illustrates a support level at 14.84, which if violated will result in even more drops to 14.52. On the upside, there is a resistance level at 15.36. A further resistance level may holdings at 15.56. The Relative Strength Index (RSI) on the 14-day chart is 40.98, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.01, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 52.26%. Stochastics %K at 42.16% indicates the stock is a holding.
How much short interest is there in Immunovant Inc?
A steep rise in short interest was recorded in Immunovant Inc stocks on 2025-03-31, growing by 4.29 million shares to a total of 19.68 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-28 was 15.39 million shares. There was a rise of 21.81%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on March 28, 2024 when Oppenheimer began covering the stock and recommended ‘”an Outperform”‘ rating along with a $50 price target.
